LAPTM5 and infection: The overexpression of LAPTM5 resulted in a 257- to 664-fold reduction in infection by CXCR4-, CCR5-, or dual-tropic Vpr-defective HIV-1, whereas the production of HIV-1 capsid was intact (Fig. 4a–c).